GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 125 filers reported holding GOSSAMER BIO INC in Q4 2020. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $117,224 | -100.0% | 54,020 | +12.7% | 0.00% | – |
| Q3 2022 | $574,453,000 | +43.1% | 47,951 | 0.0% | 0.00% | – |
| Q2 2022 | $401,349,000 | -3.6% | 47,951 | 0.0% | 0.00% | – |
| Q1 2022 | $416,214,000 | -23.3% | 47,951 | 0.0% | 0.00% | – |
| Q4 2021 | $542,326,000 | -13.3% | 47,951 | -3.6% | 0.00% | – |
| Q3 2021 | $625,257,000 | +54.8% | 49,742 | 0.0% | 0.00% | – |
| Q2 2021 | $403,906,000 | -20.1% | 49,742 | -9.0% | 0.00% | – |
| Q1 2021 | $505,532,000 | +23.1% | 54,652 | +28.7% | 0.00% | – |
| Q4 2020 | $410,511,000 | -33.8% | 42,452 | -15.0% | 0.00% | – |
| Q3 2020 | $619,904,000 | +10.8% | 49,952 | +16.0% | 0.00% | – |
| Q2 2020 | $559,676,000 | +392.3% | 43,052 | +284.4% | 0.00% | – |
| Q1 2020 | $113,680,000 | – | 11,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 8,055,916 | $6,708,967 | 4.36% |
| Velan Capital Investment Management LP | 3,065,136 | $2,552,645 | 2.06% |
| Monashee Investment Management LLC | 5,304,212 | $4,417,348 | 1.84% |
| CVI Holdings, LLC | 976,108 | $812,903 | 1.61% |
| Samsara BioCapital, LLC | 6,130,268 | $5,105,287 | 1.56% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 6,130,268 | $5,105,287 | 1.55% |
| Opaleye Management Inc. | 4,754,200 | $3,959,298 | 1.29% |
| Octagon Capital Advisors LP | 8,187,883 | $6,818,869 | 1.05% |
| NEA Management Company, LLC | 15,727,942 | $13,098,230 | 1.01% |
| GREAT POINT PARTNERS LLC | 6,230,272 | $5,188,571 | 0.94% |